Skip to main content
. Author manuscript; available in PMC: 2011 Mar 4.
Published in final edited form as: Curr Opin Mol Ther. 2010 Jun;12(3):294–304.

Figure 2. Pharmacogenetic influences on warfarin dosing.

Figure 2

(A) The warfarin drug pathway. (B) The average maintenance dose of warfarin is dependent on VKORC1 (vitamin K 2,3-epoxide reductase complex) and CYP2C9 (cytochrome P450 family 2 subfamily C polypeptide 9) genotypes (data from reference [81]).

INR international normalized ratio, V variant, WT wild-type